Literature DB >> 2375961

Cimetidine induced pancytopenia. Effect on human CFU-MIX colony formation.

W Uyttenbroeck1, M Korthout, R De Bock, D R Van Bockstaele, M E Peetermans.   

Abstract

We describe a 26 year-old male with a pancytopenia possibly due to cimetidine. Using progenitor cell culture techniques we investigated the mechanism of this bone marrow toxicity. Our results show a cimetidine dose-dependent inhibition of normal human CFU-GM colony formation as described by Fitchen and Koeffler in 1980. No differences in growth inhibition were found between the patients' recovery marrow and the controls. Toxicity on normal human CFU-MIX colony formation was, however, far more pronounced. At concentrations as low as 5 micrograms/ml the numbers of CFU-MIX colonies were decreased by almost 20% and more than 30% in cultures of two normal bone marrow samples. A significant decrease in CFU-MIX colony size was measured even at therapeutic levels (0.5 micrograms/ml). No obvious decrease in CFU-GM colony size was noticed at low concentrations. Experiments with T-cell- and monocyte-depleted bone marrow samples gave similar results: a pronounced inhibition of the CFU-MIX colony formation at low concentrations of cimetidine whereas the CFU-GM formation was less affected. It is therefore very unlikely that Accessory cells play part in the cimetidine induced CFU-MIX inhibition. Our results suggest the existence of H2 histamine receptors on human CFU-MIX (= multipotent progenitor cell). Blocking these receptors prevents the multipotent progenitor cell from going into the DNA-synthesis phase of the cell cycle.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2375961     DOI: 10.1007/bf01737845

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  32 in total

1.  Mechanism for histamine H2-receptor induced cell-cycle changes in the bone marrow stem cell.

Authors:  J W Byron
Journal:  Agents Actions       Date:  1977-07

2.  Cimetidine and bone-marrow toxicity.

Authors:  J W Byron
Journal:  Lancet       Date:  1977-09-10       Impact factor: 79.321

3.  Cimetidine and granulocytopenia.

Authors:  J W Freston
Journal:  Ann Intern Med       Date:  1979-02       Impact factor: 25.391

4.  Bone-marrow toxicity of metiamide.

Authors:  J W Byron
Journal:  Lancet       Date:  1976-12-18       Impact factor: 79.321

5.  Cimetidine and thrombocytopenia.

Authors:  A J Isaacs
Journal:  Br Med J       Date:  1980-02-02

6.  Cimetidine and granulopoiesis: bone marrow culture studies in normal man and patients with cimetidine-associated neutropenia.

Authors:  J H Fitchen; H P Koeffler
Journal:  Br J Haematol       Date:  1980-11       Impact factor: 6.998

7.  A miniaturized agar culture system for cloning human erythropoietic progenitor cells.

Authors:  G Konwalinka; C Peschel; J Boyd; D Geissler; M Ogriseg; R Odavic; H Braunsteiner
Journal:  Exp Hematol       Date:  1984-01       Impact factor: 3.084

8.  In-vitro cloning techniques for hemopoietic cells: clinical applications.

Authors:  D Metcalf
Journal:  Ann Intern Med       Date:  1977-10       Impact factor: 25.391

9.  Comparison of the effects of 4-methylhistamine on the cell-cycle response between CFU-s and its subpopulation.

Authors:  Z C Tang; Y H Xu
Journal:  Int J Cell Cloning       Date:  1987-11

10.  Pharmacodynamic basis for the interaction of cimetidine with the bone marrow stem cells (CFUS).

Authors:  J W Byron
Journal:  Exp Hematol       Date:  1980-03       Impact factor: 3.084

View more
  2 in total

1.  The growth capacity of hematopoietic progenitor cells in severe neutropenia induced by famotidine.

Authors:  T Liersch; J H Beyer; G Krieger; K Vehmeyer
Journal:  Ann Hematol       Date:  1992-05       Impact factor: 3.673

Review 2.  A comparative overview of the adverse effects of antiulcer drugs.

Authors:  D W Piper
Journal:  Drug Saf       Date:  1995-02       Impact factor: 5.606

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.